Search results for "performance"

showing 10 items of 4457 documents

A healthy Nordic diet and physical performance in old age : findings from the longitudinal Helsinki Birth Cohort Study

2016

AbstractEpidemiological studies have shown that a number of nutrients are associated with better physical performance. However, little is still known about the role of the whole diet, particularly a healthy Nordic diet, in relation to physical performance. Therefore, we examined whether a healthy Nordic diet was associated with measures of physical performance 10 years later. We studied 1072 participants from the Helsinki Birth Cohort Study. Participants’ diet was assessed using a validated 128-item FFQ at the mean age of 61 years, and a priori-defined Nordic diet score (NDS) was calculated. The score included Nordic fruits and berries, vegetables, cereals, PUFA:SFA and trans-fatty acids ra…

Male0301 basic medicineGerontologyMediterranean dietMedicine (miscellaneous)VITAMIN-D STATUSSenior Fitness TestBody Mass IndexPhysical performanceCohort Studies0302 clinical medicine3123 Gynaecology and paediatricsSurveys and QuestionnairesVegetablesEpidemiologyLongitudinal StudiesMicronutrients030212 general & internal medicineMETABOLIC SYNDROMENutrition and DieteticsFatty AcidsFishesBALTIC SEA DIETta3141ta3142ASSOCIATIONMiddle AgedTrans Fatty AcidsMicronutrientMEDITERRANEAN DIETMilkFatty Acids UnsaturatedFemaleDietary ProteinsCohort studymedicine.medical_specialtyMeatMotor Activity03 medical and health sciencesDietary CarbohydratesmedicineAnimalsHumansFOOD FREQUENCY QUESTIONNAIRE030109 nutrition & dieteticsbusiness.industryNordic dietWOMENS HEALTHADULTSmedicine.diseaseDietary FatsDietBODY-MASS INDEXAgeingLOWER-EXTREMITY FUNCTIONNutrition AssessmentSeafood416 Food SciencePhysical performanceAgeingFruitMetabolic syndromeEdible GrainEnergy IntakebusinessBody mass indexFollow-Up StudiesDemography
researchProduct

Analysis of Functional and Cognitive Impairment in Institutionalized Individuals with Movement Disorders

2018

Background: Many neurological disorders lead to institutionalization and can be accompanied in their advanced stages by functional impairment, and progressive loss of mobility, and cognitive alterations. Objective: We analyzed the relationship between functional impairment and cognitive performance and its related subdomains in individuals with Parkinson’s disease, Alzheimer’s disease accompanied by motor dysfunction, and with other neurological disorders characterized by both motor and cognitive problems. Methods: All participants lived in nursing homes (Valencia, Spain) and underwent cognitive evaluation with the Mini-Mental State Examination; functional assessment of independence in act…

Male0301 basic medicineMovement disordersActivities of daily livingParkinson's diseaseEndocrinology Diabetes and MetabolismOverweight03 medical and health sciences0302 clinical medicinemedicineHomes for the AgedHumansImmunology and AllergyMemory impairmentCognitive DysfunctionEffects of sleep deprivation on cognitive performanceAgedAged 80 and overCognitive evaluation theoryMovement Disordersbusiness.industryInstitutionalizationCognitionMental Status and Dementia Testsmedicine.diseaseNursing Homes030104 developmental biologySpainFemalemedicine.symptombusiness030217 neurology & neurosurgeryClinical psychologyEndocrine, Metabolic & Immune Disorders - Drug Targets
researchProduct

Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multice…

2018

Summary Background Encorafenib plus binimetinib and encorafenib alone improved progression-free survival compared with vemurafenib in patients with BRAF V600 -mutant melanoma in the COLUMBUS trial. Here, we report the results of the secondary endpoint of overall survival. Methods COLUMBUS was a two-part, randomised, open-label, phase 3 study done at 162 hospitals in 28 countries. Eligible patients were aged at least 18 years with histologically confirmed, locally advanced, unresectable, or metastatic cutaneous melanoma, or unknown primary melanoma, BRAF V600E or BRAF V600K mutation, an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, and were treatment naive or had pr…

Male0301 basic medicineOncologySkin NeoplasmsTime FactorsMedizinPhases of clinical researchGene mutationchemistry.chemical_compound0302 clinical medicineAntineoplastic Combined Chemotherapy ProtocolsVemurafenibMelanomaAged 80 and overTrametinibSulfonamides10177 Dermatology ClinicBinimetinibMiddle AgedProgression-Free SurvivalPhenotypeOncologyTolerability030220 oncology & carcinogenesisDisease ProgressionFemale2730 Oncologymedicine.drugAdultProto-Oncogene Proteins B-rafmedicine.medical_specialty610 Medicine & healthYoung Adult03 medical and health sciencesInternal medicineBiomarkers TumormedicineHumansGenetic Predisposition to DiseaseProgression-free survivalProtein Kinase InhibitorsAgedPerformance statusbusiness.industry030104 developmental biologyVemurafenibchemistryMutationBenzimidazolesCarbamatesbusinessThe Lancet Oncology
researchProduct

The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with …

2016

// Giuseppe Bronte 1, * , Tindara Franchina 2, * , Massimiliano Alu 3, * , Giovanni Sortino 1 , Claudia Celesia 1 , Francesco Passiglia 1 , Giuseppina Savio 3 , Agata Laudani 3 , Alessandro Russo 2 , Antonio Picone 2 , Sergio Rizzo 1 , Michele De Tursi 4 , Elisabetta Gambale 4 , Viviana Bazan 1 , Clara Natoli 4 , Livio Blasi 3 , Vincenzo Adamo 2 , Antonio Russo 1 1 Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy 2 Medical Oncology Unit-AOOR Papardo-Piemonte, Messina and Department of Human Pathology, University of Messina, Messina, Italy 3 Medical Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy 4 Department of Medical, Oral and Biotechnological …

Male0301 basic medicineOncologymedicine.medical_specialtyLung Neoplasmsmedicine.drug_classEGFRTyrosine kinase inhibitorKaplan-Meier EstimateTyrosine-kinase inhibitorErlotinib Hydrochloride03 medical and health sciences0302 clinical medicineGefitinibCarcinoma Non-Small-Cell LungInternal medicinemedicineHumansChemotherapyErlotinib HydrochlorideLung cancerProtein Kinase InhibitorsChemotherapy EGFR Non-small-cell lung cancer Tyrosine kinase inhibitor OncologyAgedRetrospective StudiesAged 80 and overPerformance statusbusiness.industryChemotherapy; EGFR; Non-small-cell lung cancer; Tyrosine kinase inhibitor; OncologyGefitinibRetrospective cohort studyMiddle Agedmedicine.diseaserespiratory tract diseasesSurgeryErbB ReceptorsClinical trialTreatment Outcome030104 developmental biologyOncology030220 oncology & carcinogenesisMutationQuinazolinesFemaleErlotinibbusinessNon-small-cell lung cancerResearch Papermedicine.drug
researchProduct

Neuroligin-2 Expression in the Prefrontal Cortex is Involved in Attention Deficits Induced by Peripubertal Stress

2016

Emerging evidence indicates that attention deficits, which are frequently observed as core symptoms of neuropsychiatric disorders, may be elicited by early life stress. However, the mechanisms mediating these stress effects remain unknown. The prefrontal cortex (PFC) has been implicated in the regulation of attention, including dysfunctions in GABAergic transmission, and it is highly sensitive to stress. Here, we investigated the involvement of neuroligin-2 (NLGN-2), a synaptic cell adhesion molecule involved in the stabilization and maturation of GABAergic synapses, in the PFC in the link between stress and attention deficits. First, we established that exposure of rats to stress during th…

Male0301 basic medicineSerial reaction timeCell Adhesion Molecules NeuronalGenetic VectorsGlutamate decarboxylasePrefrontal CortexNerve Tissue ProteinsNeuropsychological Testsgamma-Aminobutyric acidRandom Allocation03 medical and health sciences0302 clinical medicineContinuous performance taskCortex (anatomy)medicineAnimalsAttentionRNA MessengerSexual MaturationRats WistarPrefrontal cortexgamma-Aminobutyric AcidPharmacologymedicine.diagnostic_testCognitionDependovirusImmunohistochemistryDisease Models AnimalPsychiatry and Mental health030104 developmental biologymedicine.anatomical_structureAttention Deficit Disorder with HyperactivityGABAergicOriginal ArticlePsychologyNeuroscienceStress Psychological030217 neurology & neurosurgerymedicine.drugNeuropsychopharmacology
researchProduct

Mild cognitive impairment in Parkinson’s disease: the Parkinson’s disease cognitive study (PACOS)

2018

Approximately 30% of Parkinson's disease (PD) patients show impaired cognitive performance, which is suggestive of Mild Cognitive Impairment (MCI), representing a predictor of dementia, especially when present at diagnosis. The objective of the study was to evaluate the frequency and clinical predictors of MCI in a large hospital-based cohort of PD patients. We collected cross-sectional data from the Parkinson's disease cognitive impairment study (PACOS), a multicenter study involving two Movement Disorder centers, which are located in south Italy. The PD subjects were diagnosed according to the UK Brain Bank criteria and they underwent an extensive neuropsychological assessment. PD-MCI was…

Male0301 basic medicinemedicine.medical_specialtyNeurologyParkinson's diseaseEpidemiologyParkinson's diseaseNeuropsychological TestsLogistic regressionSeverity of Illness Index03 medical and health sciences0302 clinical medicineInternal medicinemental disordersEpidemiologyOdds RatioPrevalenceHumansMedicineDementiaCognitive DysfunctionParkinsonâ s diseaseEffects of sleep deprivation on cognitive performanceNeuropsychological assessmentAge of OnsetCognitive impairment; Epidemiology; Parkinson’s disease; Prevalence; Neurology; Neurology (clinical)AgedRetrospective Studiesmedicine.diagnostic_testbusiness.industryParkinson Diseasemedicine.diseasenervous system diseasesCross-Sectional StudiesCognitive impairment030104 developmental biologyNeurologyMultivariate AnalysisCohortEducational StatusSettore MED/26 - NeurologiaFemaleAmnesiaNeurology (clinical)businesshuman activities030217 neurology & neurosurgeryJournal of Neurology
researchProduct

Bigger is not better: cortisol-induced cardiac growth and dysfunction in salmonids

2015

This is a Published Manuscript of an article published by Company of Biologists in Journal of Experimental Biology, available online: http://www.biologists.com/ Stress and elevated cortisol levels are associated with pathological heart growth and cardiovascular disease in humans and other mammals. We recently established a link between heritable variation in post-stress cortisol production and cardiac growth also in salmonid fish. A conserved stimulatory effect of the otherwise catabolic steroid hormone cortisol is likely implied, but has to date not been established experimentally. Furthermore, whereas cardiac growth is associated with failure of the mammalian heart, pathological cardiac h…

Male0301 basic medicinemedicine.medical_specialtyendocrine systemHydrocortisonePhysiologyGene ExpressionHeart failureCardiac performance030204 cardiovascular system & hematologyAquatic ScienceBiologyBioinformatics03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingInternal medicinemedicineAnimalsChronic stressCardiac OutputMolecular BiologySwimmingEcology Evolution Behavior and SystematicsVentricular RemodelingHeartStroke VolumeHypertrophyMyocardial hypertrophymedicine.diseasePeer reviewRainbow trout030104 developmental biologyEndocrinologyOncorhynchus mykissInsect ScienceHeart failureMyocardial hypertrophy/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingExperimental biologyChronic stressFemaleAnimal Science and ZoologyRainbow trout
researchProduct

A combined therapy for limb apraxia and related anosognosia.

2019

Left hemisphere stroke frequently leads to limb apraxia, a disorder that has been reported to impact independence in daily life and rehabilitation success. Nonetheless, there is a shortcoming in research and availability of applicable trainings. Further, to date, anosognosia for limb apraxia has largely been neglected. Therefore, we developed a Naturalistic Action Therapy that trains object selection and application with an errorless learning approach and which includes supported self-evaluation. The current study presents the results of two stroke patients participating in the training. The procedure entailed two baseline and one post-training sessions including standardized limb apraxia a…

Male030506 rehabilitationmedicine.medical_specialtygenetic structuresApraxiasmedia_common.quotation_subjectmedicine.medical_treatmenteducationbehavioral disciplines and activitiesLateralization of brain functionUpper Extremity03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationddc:150Arts and Humanities (miscellaneous)Occupational TherapymedicineHumansStrokeApplied Psychologymedia_commonAgedAged 80 and overRehabilitationbusiness.industryAnosognosiaRehabilitationStroke RehabilitationLimb apraxiaMiddle Agedmedicine.diseaseNaturalistic Action Therapy limb apraxia Anosognosia for apraxia rehabilitation tool-useIndependencebody regionsStrokeNeuropsychology and Physiological PsychologyAgnosiaCombined therapyFemale0305 other medical sciencebusiness030217 neurology & neurosurgeryPsychomotor PerformanceNeuropsychological rehabilitation
researchProduct

Subclinical levels of anxiety but not depression are associated with planning performance in a large population-based sample

2017

BackgroundMajor depression and anxiety disorders are known to negatively influence cognitive performance. Moreover, there is evidence for greater cognitive decline in older adults with generalized anxiety disorder. Except for clinical studies, complex executive planning functions and subclinical levels of anxiety have not been examined in a population-based sample with a broad age range.MethodsPlanning performance was assessed using the Tower of London task in a population-based sample of 4240 participants aged 40–80 years from the Gutenberg Health Study (GHS) and related to self-reported anxiety and depression by means of multiple linear regression analysis.ResultsHigher anxiety ratings we…

Male050103 clinical psychologymedicine.medical_specialtyGeneralized anxiety disorderPopulationAnxietyNeuropsychological TestsExecutive Function03 medical and health sciencesCognition0302 clinical medicineGermanyHumansMedicineCognitive Dysfunction0501 psychology and cognitive sciencesProspective StudiesEffects of sleep deprivation on cognitive performanceCognitive declineeducationPsychiatryProblem SolvingApplied PsychologyDepression (differential diagnoses)AgedSubclinical infectioneducation.field_of_studyDepressionbusiness.industry05 social sciencesCognitionMiddle Agedmedicine.disease030227 psychiatryPsychiatry and Mental healthCross-Sectional StudiesLinear ModelsAnxietyFemalemedicine.symptombusinessPsychomotor PerformanceClinical psychologyPsychological Medicine
researchProduct

The relationship between ADHD and key cognitive phenotypes is not mediated by shared familial effects with IQ

2011

BackgroundTwin and sibling studies have identified specific cognitive phenotypes that may mediate the association between genes and the clinical symptoms of attention deficit hyperactivity disorder (ADHD). ADHD is also associated with lower IQ scores. We aimed to investigate whether the familial association between measures of cognitive performance and the clinical diagnosis of ADHD is mediated through shared familial influences with IQ.MethodMultivariate familial models were run on data from 1265 individuals aged 6–18 years, comprising 920 participants from ADHD sibling pairs and 345 control participants. Cognitive assessments included a four-choice reaction time (RT) task, a go/no-go task…

Male110 012 Social cognition of verbal communicationInhibition (Psychology)PsychometricsIntelligenceMedizinPerception and Actions Mental Health [DCN 1]CHILDRENCHILDHOOD ADHDNeuropsychological TestsheritabilityPersonality AssessmentChoice BehaviorDevelopmental psychology0302 clinical medicineExterne » Sonstige EinrichtungenMedicine and Health SciencesPerception and Action [DCN 1]ChildInternal-External ControlApplied PsychologyIntelligence quotientATTENTION-DEFICIT/HYPERACTIVITY DISORDERCognitionEuropeInhibition PsychologicalPsychiatry and Mental healthPhenotypeFemalemedicine.symptomPsychologyFunctional Neurogenomics [DCN 2]AdolescentPsychometricsDEFICIT HYPERACTIVITY DISORDERintermediate phenotypeINHIBITIONImpulsivityMental health [NCEBP 9]behavioral disciplines and activitiesArticle150 000 MR Techniques in Brain FunctioncognitiveADHD; cognitive; heritability; IQ; intermediate phenotype03 medical and health sciencesRewardmental disordersReaction TimemedicineHumansAttention deficit hyperactivity disorderADHDEffects of sleep deprivation on cognitive performanceddc:610SiblingENDOPHENOTYPESDELAY AVERSIONPERFORMANCEmedicine.disease030227 psychiatryAttention Deficit Disorder with HyperactivityIQEndophenotypeMultivariate AnalysisRESPONSE VARIABILITYSUSTAINED ATTENTIONCognition Disorders030217 neurology & neurosurgeryPsychological Medicine
researchProduct